Cargando…

Anticoagulant properties of enoxaparin 400 IU/mL–40 % ethanol catheter lock solution

Unfractionated heparin (UFH) is the most widely used interdialytic lock solution but has no anti-infectious properties. Ethanol at a content ≥40 %v/v eradicates experimental biofilm but has no anticoagulant properties. In contrast to UFH, enoxaparin (Enox) can be combined with 40 % ethanol without p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvet, Laure, Piot, Michèle, Lartigue, Claire, Souweine, Bertrand, Tardy-Poncet, Brigitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666847/ https://www.ncbi.nlm.nih.gov/pubmed/26693105 http://dx.doi.org/10.1186/s40064-015-1533-2

Ejemplares similares

Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
por: Balestrino, Damien, et al.
Publicado: (2016)

Evaluation of the efficacy of an interdialytic “ethanol 40% v/v - enoxaparin 1000 U/mL” lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study
por: Aniort, Julien, et al.
Publicado: (2019)

Prevention of Vitamin D deficiency in infancy: daily 400 IU vitamin D is sufficient
por: Mutlu, Gul Yesiltepe, et al.
Publicado: (2011)

Vitamin D Deficiency in Mexican Pregnant Women: Is Supplementation with ≤400 IU/day Enough?
por: Perichart-Perera, Otilia, et al.
Publicado: (2020)

Are Vitamin D Drops Containing 400 IU Daily Adequate for Preventing Vitamin D Deficiency?
por: Korkmaz, Hüseyin Anıl
Publicado: (2016)

Catheter Lock with Minocycline, EDTA and Ethanol for Salvaging of Central Venous Catheters in the Setting of Catheter-related Bloodstream Infections
por: Hachem, Ray Y, et al.
Publicado: (2017)

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
por: Menzella, Francesco, et al.
Publicado: (2023)

A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis
por: Saini, Vikas, et al.
Publicado: (2018)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Ethanol Causes Protein Precipitation—New Safety Issues for Catheter Locking Techniques
por: Schilcher, Gernot, et al.
Publicado: (2013)

Pure Stage I Seminoma with an Elevated hCG of 25,265 mIU/ml: A Case Report
por: Katayama, Hiromichi, et al.
Publicado: (2016)

ADVANCED LIVER INJURY IN PATIENTS WITH CHRONIC HEPATITIS B AND VIRAL LOAD BELOW 2,000 IU/mL
por: de OLIVEIRA, Valter Oberdan Borges, et al.
Publicado: (2016)

Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B With HBsAg < 100 IU/ml
por: Wu, Yingping, et al.
Publicado: (2021)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
por: Li, Hong, et al.
Publicado: (2022)

Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study
por: Huang, Xu, et al.
Publicado: (2022)

HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
por: Morgan, Jake R., et al.
Publicado: (2021)

In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions
por: Parra, Diego, et al.
Publicado: (2015)

Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000–20000 IU/ml with ALT 1–2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT
por: Danis, Nilay, et al.
Publicado: (2021)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

Cardiac Murmurs Iu Chorea
Publicado: (1871)

Conservative Management of Interstitial Pregnancy With Beta-hCG of Over 39,000 mIU/mL: A Case Report
por: Mayuga, Tom J, et al.
Publicado: (2022)

Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023)

Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model?
por: Alonso, Beatriz, et al.
Publicado: (2019)

Prevention of Catheter-Related Bacteremia with a Daily Ethanol Lock in Patients with Tunnelled Catheters: A Randomized, Placebo-Controlled Trial
por: Slobbe, Lennert, et al.
Publicado: (2010)

Accidental withdrawal of catheters in 400 patients in ICU
por: Lorente, L, et al.
Publicado: (2002)

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study
por: Ranathunga, R.M.T.K., et al.
Publicado: (2019)

Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding
por: Hughes, Steven D, et al.
Publicado: (2009)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
por: Yao, Chih-Chien, et al.
Publicado: (2017)

Proliferation and migration of ML1 follicular thyroid cancer cells are inhibited by IU1 targeting USP14: role of proteasome and autophagy flux
por: Srinivasan, Vignesh, et al.
Publicado: (2023)

Correction: Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model?
por: Alonso, Beatriz, et al.
Publicado: (2019)

Ethanol locks for the prevention of catheter-related bloodstream infection: a meta-analysis of randomized control trials
por: Zhang, Peng, et al.
Publicado: (2018)

2100. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective in Eradicating Candida auris Biofilms
por: Rosenblatt, Joel, et al.
Publicado: (2018)

IU professor contributes to particle accelerator
Publicado: (2008)

Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon(® )Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon(®)) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section
por: Murphy, Deirdre J, et al.
Publicado: (2009)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022)

Enoxaparin as an Anticoagulant in a Multipara with a Mechanical Mitral Valve: A Case Report
por: Lee, Yo Seb, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sdgb64b6304vff8fla0eaonjmt